What the FDA labels say about taking them together
Azilsartan and lithium
Azilsartan's FDA label of January 23, 2024 names lithium in its drug interactions section; the lithium labels PlainMeds reads (4) do not name azilsartan. The azilsartan label: “Increases in serum lithium concentrations and lithium toxicity.”
Check it at the source: the azilsartan FDA label on DailyMed (effective January 23, 2024, Azurity Pharmaceuticals, Inc.); the lithium FDA label on DailyMed (effective December 23, 2025, Glenmark Pharmaceuticals Inc., USA).
What does the azilsartan label say about lithium?
Azilsartan label, drug interactionsIncreases in serum lithium concentrations and lithium toxicity.
Source: FDA drug label (Edarbi), Azurity Pharmaceuticals, Inc., effective January 23, 2024 (SPL set 52b27c75-9f5a-4816-bafd-dace9d7d2063), via openFDA; the full label on DailyMed
What does the lithium label say about azilsartan?
Lithium's label (effective December 23, 2025) and its 3 other brand-application labels do not name azilsartan in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Lithium Carbonate), Glenmark Pharmaceuticals Inc., USA, effective December 23, 2025 (SPL set 63b3790f-a9b5-47f4-bae1-ddf8b43c13c1), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Azilsartan | Lithium | |
|---|---|---|
| Labeled for | High blood pressure | Bipolar disorder |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | $5.47 per tablet 40 mg tablet | $0.104 per capsule 300 mg capsule |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once